Advanced Search
Wang Xianglian, Fu Meina, Wang Guomin. Diagnosis and Treatment of Esthesioneuroblastoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1250-1252. DOI: 10.3971/j.issn.1000-8578.2012.10.022
Citation: Wang Xianglian, Fu Meina, Wang Guomin. Diagnosis and Treatment of Esthesioneuroblastoma[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1250-1252. DOI: 10.3971/j.issn.1000-8578.2012.10.022

Diagnosis and Treatment of Esthesioneuroblastoma

More Information
  • Received Date: December 07, 2011
  • Revised Date: February 01, 2012
  • Objective To discuss correlation factor of diagnosis,treatment and prognosis of esthesioneuroblastoma (ENB). Methods The data of 12 patients with ENB treated from January 1994 to May 2010 were retrospectively reviewed in this study.one patient had modified Kadish stage A disease,five patients had modified Kadish stage B disease,three patients stage C,three patients in stage D.six patients were treated with comprehensive therapies including surgery,four patients were treated with surgery alone,one patient was treated with radiotherapy alone,one patient was treated with chemotherapy alone. Results The 5-year overall survival (OS) and disease free survival (DFS) of the whole group were 90.9% and 74.1% respectively.The 5-year OS of modified Kadish's stage A,B and C,D were 100% and 80.0%(χ2=1.20,P=0.27).And the 5-year DFS were 100% and 44.4%(χ2=4.07,P=0.04),respectively.The 5-year OS for patients with cervical lymph node metastasis and without cervical lymph node metastasis were 6.7% and 100% (χ2=2.67,P=0.10) The 5-year DFS were 33.3% and 87.5%(χ2=4.88,P=0.03).The 5-year OS for patients treated with combined therapy and single treatment were 100% and 80.0%(χ2=1.20,P=0.27),the 5-year DFS of them were 83.3% and 62.5%(χ2=0.35,P=0.88),respectively. Conclusion It's difficult for early diagnose of ENB,the therapeutic effect of comprehensive therapy is better,radiotherapy is important for ENB.The prognosis of this disease is connected with the stage of the disease and lymph node metastasis.
  • [1]
    Holland H,Koschny R,Krupp W,et al.Comprehensive cytogenetic characterization of an esthesioneuroblastoma[J].Cancer Genet Cytogenet,2007,173(2):89-96.
    [2]
    Liu MB,Chen L,Wang JL,et al.An Analysis of Comprehensive Treatment in 31 Cases with Esthesioneuroblastoma[J].Zhong Liu Xue Za Zhi,2009,15(1):50.[刘明波,陈雷,王嘉陵,等.嗅神经母细胞瘤31例综合治疗分析[J].肿瘤学杂志,2009,15(1):50.]
    [3]
    Richard J Harvey,Winder M,Parmar P,et al.Endoscopic skull base surgegy for sinonasal malignancy[J].Otolaryngol Clin North Am,2011,44(5):1081-140.
    [4]
    Taneja AK,Reis F,Queiroz LS,et al.Esthesioneuroblastoma[J].Arq Neropsiquiatr,2009,67(3A):704-6.
    [5]
    Cheng C,Long XB.Diagnosis and treatment of esthesioneuroblastoma in the nasal cavity and sinuses[J].NanFang Yi Ke Da Xue Xue Bao,2010,30(10):2402-3.[程超,龙孝斌.嗅神经母细胞瘤临床诊断与治疗探讨[J].南方医科大学学报,2010,30(10):2402-3.]
    [6]
    Gong QY,Wu XS.Clinical Analysis of 36 Cases of Esthesioneuro- blastoma[J].Shi Yong Ai Zheng ZaZhi,2010,25(1):69.[龚巧英,吴新生.嗅神经母细胞瘤36例临床分析[J].实用癌症杂志,2010,25(1):69.]
    [7]
    Morris L,Govindaraj S,Genden EM.Primary sphenoid sinus esthesioneu- roblastoma[J].Am J Otolaryngol,2004,25(5):350-53.
    [8]
    Noh OK,Lee SW,Yoon SM,et al.Radiotherapy for esthesio- neuroblastoma :is elective nodal irradiationwarranted in the multimodality treatment approach?[J].Int J Radiation Oncol Biol Phys,2011,79(2):443-9.
    [9]
    Zhao LJ,Gao L.Diagnosis and treatment of esthesioneuroblastoma[J].Zhonghua Fang She Zhong Liu Xue ZaZhi,2003,12(4):281-4.[赵路军,高黎.嗅神经母细胞瘤的诊断和治疗现状[ J ].中华放射肿瘤学杂志,2003,12 (4) :281-4.]
    [10]
    Wang J,Ke ZW,Yang WY,et al.Analysis on the Misdiagnosis of Esthesio-neuroblastoma [J].Xi′nan JunYi,2006,8(3):30-2.[王进,柯振武,杨伟炎,等.嗅神经母细胞瘤误诊原因分析[J].西南军医,2006,8(3):30-2.]
    [11]
    Liu Y,Ma TX,Luan L,et al.CT and MRI findings of olfactory neuroblastoma [J].Zhongguo Zhong Xi Yi Jie HeYing Xiang Xue Za Zhi,2010,8(2):140-1.[刘颖,马天璇,栾玲,等.嗅神经母细胞瘤的CT与MRI影像分析[J].中国中西医结合影像学杂志,2010,8(2):140-1.]
    [12]
    McLean JN,Nunley SR,Klass C,et al.Combined modality therapy of esthesioneuroblastoma[J].Otolaryngol HeadNeck Surg,2007,136(6):998-1002.
    [13]
    Dulguerov P,Allal AS,Calcaterra TC.Esthesioneuroblastoma :a meta-analysis and review[J].LancetOncol,2001,2 (11):683-90.
    [14]
    Gruber G,Laedrach K,Baumert B,et al.Esthesioneuroblastoma:irradiation alone and surgery alone are notenough [J].Int J Radiat Oncol Biol Phys,2002,54(2):486-91.
    [15]
    Foote RL,Morita A,Ebersold MJ,et al.Esthesioneuroblastoma:the role of adjuvant radiation therapy[J].Int JRadiat Oncol Biol Phys,1993,27(4):835-42.
    [16]
    Zhao LJ,Gao L,Xu GZ,et al.Prognostic factors and outcome of esthesioneuroblastoma[J].Zhonghua Zhong LiuZa Zhi,2005,27(9):564.[赵路军,高黎,徐国镇,等.嗅神经母细胞瘤的预后因素和治疗结果分析[J].中华肿瘤杂志,2005,27(9):564.]
    [17]
    Lv ZC,Liu HG.The research progress of esthesioneuroblastoma[J].Zhen Duan Bing Li Xue Za Zhi,2007,14(5):385.[吕智春,刘红刚.嗅神经母细胞瘤研究进展[J].诊断病理学杂志,2007,14(5):385.]
    [18]
    Diaz EM Jr,Rohnigan RH 3rd,Peru C,et al.Olfactory neuroblastoma:the 22-year experience at onecomprehensive cancer center [J].Head Neck,2005,27(2):138-49.
  • Related Articles

    [1]XIA Lin, YU Guozheng, TANG Jing. Diagnostic Value of Circular RNAs for Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(9): 864-870. DOI: 10.3971/j.issn.1000-8578.2021.21.0069
    [2]LIANG Tong, LIU Huajie, DA Mingxu. Metabolic Syndrome and Risk of Gastric Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 268-273. DOI: 10.3971/j.issn.1000-8578.2021.20.0957
    [3]JIAN Yaowen, WANG Lei, Liu Ye, HE Mingyan, RANG Weiqing. A Meta-analysis of Dietary Vitamin Consumption and Risk of Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2020, 47(2): 108-111. DOI: 10.3971/j.issn.1000-8578.2020.19.0007
    [4]ZHAO Rongchang, YU Wenyan, FENG Yuxin, ZHANG Wanli, ZHU Chunrong. Comparison of Efficacy Between S-1 and Capecitabine/Fluorouracil on Advanced Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1123-1130. DOI: 10.3971/j.issn.1000-8578.2019.19.0138
    [5]RAO Xionghui, LUO Hongliang, HUANG Jun, ZHU Zhengming. Prognostic and Clinicopathological Significance of PD-L1 Expression for Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 1013-1021. DOI: 10.3971/j.issn.1000-8578.2019.19.0363
    [6]JIAN Yaowen, XIONG Wenjing, LIU Ye, LIU Yang, YANG Huixian, RANG Weiqing. A Meta-analysis on Relationship of Dietary Factors with Liver Cancer in Chinese Population[J]. Cancer Research on Prevention and Treatment, 2017, 44(7): 493-500. DOI: 10.3971/j.issn.1000-8578.2017.16.1465
    [7]YU Huihui, WEI Lixuan, LIU Yunyong, XING Xiaojing. Meta-analysis of Relationship Between Blood 25-hydroxyvitamin D Level and Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 394-398. DOI: 10.3971/j.issn.1000-8578.2015.04.017
    [8]LIU Min, SONG Yang, YANG Fuguo. Effect of Food Intake on Risk of Rectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1343-1347. DOI: 10.3971/j.issn.1000-8578.2014.12.020
    [9]Yao Zhiwen, Zhao Zhenlong, Jiang Yumei, Mi Ying, Gu Miaoning. Meta-analysis for Association between Polymorphism of COX-2 -1195G>A and Colorectal Cancer Susceptibility[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 213-217. DOI: 10.3971/j.issn.1000-8578.2012.02.024
    [10]QIU Yue-feng, CAI Lin. Meta-analysis on Relationship between Body Mass Index and Lung Cancer Risk[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 218-222. DOI: 10.3971/j.issn.1000-8578.2010.02.025

Catalog

    Article views (2938) PDF downloads (741) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return